Related Experiment Video
Updated: Jul 9, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Summary
Cerebral palsy is primarily caused by ischemic or asphyxial damage, often occurring in preterm infants or those experiencing perinatal asphyxia. Risk factors frequently interact, making cerebral palsy a complex, multifactorial condition.
Area of Science:
- Neurology
- Pediatrics
- Perinatal Medicine
Background:
- Cerebral palsy (CP) arises from diverse insults, with ischemia and asphyxia being the predominant damage mechanisms.
- Understanding the multifactorial nature of CP is crucial, as risk factors often interact, influencing susceptibility and outcomes.
Purpose of the Study:
- To delineate the primary etiologic factors contributing to cerebral palsy.
- To estimate the relative contributions of various risk factor groups to the overall burden of cerebral palsy.
Main Methods:
- Analysis of risk factor contributions to cerebral palsy burden, acknowledging limitations in knowledge and factor interactions.
- Categorization of cerebral palsy etiologies based on infant characteristics and perinatal events.
Main Results:
- Preterm/low birthweight infants represent the largest group with cerebral palsy, often linked to perinatal ischemic damage.
- Infants born at term experiencing severe perinatal asphyxia constitute the second largest etiological group.
- While congenital infections and hyperbilirubinemia play a role, genetic conditions are rarely the primary cause; intrauterine ischemia's significance is under investigation.
Conclusions:
- Ischemic and asphyxial insults are the dominant causes of cerebral palsy.
- Cerebral palsy is frequently multifactorial, with interactions between risk factors like prematurity and asphyxia.
- Further research is needed to fully understand the role of intrauterine events in cerebral palsy etiology.
More Related Videos
Related Concept Videos
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...